Advancing a new era in treatment to help people gain control of movement
It is time for people living with movement disorders to expect more
Vima Therapeutics is on a mission to change the lives of people living with dystonia and Parkinson's disease by developing a novel oral therapy designed to help patients regain control of their movement. Dystonia is a chronic, disabling movement disorder that occurs in both adults and children and has no cure. It shares underlying biology with other movement disorders, including Parkinson's disease and dystonic cerebral palsy, which together affect more than one million people in the United States alone.
Hear Ben's story in his own words
Meet Ben, 16, who struggled with a movement disorder for four years until he was diagnosed with dystonia. Ben describes the impact dystonia has had on his life as a teenager and his thoughts for the future.
Working to change how movement disorders are treated
We are focused on ushering in a new era of treatment that targets the underlying biology of disease.
Our team
We are a team of doctors, scientists, and experts in movement disorders, with decades of experience developing treatments for neurological diseases. Learn more about our team.
News
Learn about our progress and latest milestones.
